These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8237956)

  • 21. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined hepatocellular and cholangiocellular carcinoma: a case report with invasion to the left hepatic duct of hepatocellular carcinoma].
    Ogata T; Ohwada S; Fukusato T; Nakamura S; Kawashima Y; Morishita Y; Matsumoto M; Kon Y
    Nihon Shokakibyo Gakkai Zasshi; 1996 Jun; 93(6):428-32. PubMed ID: 8752762
    [No Abstract]   [Full Text] [Related]  

  • 25. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation.
    Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K
    Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1083-6. PubMed ID: 12143207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined hepatocellular-cholangiocarcinoma presented with massive pulmonary embolism.
    Koskinas J; Betrosian A; Kafiri G; Tsolakidis G; Garaziotou V; Hadziyannis S
    Hepatogastroenterology; 2000; 47(34):1125-8. PubMed ID: 11020895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report combined hepatocellular and cholangiocarcinoma with sarcomatous transformation.
    Boonsakan P; Thangnapakorn O; Tapaneeyakorn J; Kositchaiwat S; Bunyaratvej S
    J Med Assoc Thai; 2007 Mar; 90(3):574-80. PubMed ID: 17427538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
    Furuta T; Kanematsu T; Sonoda T; Sugimachi K
    Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases.
    Song JS; Lee YJ; Kim KW; Huh J; Jang SJ; Yu E
    Pathol Int; 2008 Aug; 58(8):503-12. PubMed ID: 18705771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature.
    Chin S; Kim Z
    Int J Clin Exp Pathol; 2014; 7(11):8290-4. PubMed ID: 25550887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Ogawa M; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1092-4. PubMed ID: 12143210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [E-cadherin].
    Kato M; Terada T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():195-200. PubMed ID: 11761940
    [No Abstract]   [Full Text] [Related]  

  • 37. Sarcomatous cholangiocarcinoma.
    Gupta K; Powari M; Dey P
    Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
    [No Abstract]   [Full Text] [Related]  

  • 38. [Histological classification of hepatocellular carcinoma].
    Kojiro M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():203-15. PubMed ID: 11761942
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined hepatocellular-cholangiocarcinoma in a lesser flamingo (Phoenicopterus minor).
    Van Wettere AJ; Degernes LA; Barnes HJ
    Avian Pathol; 2010 Aug; 39(4):275-8. PubMed ID: 20706883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
    Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
    Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.